<li>aminobenzoate potassium<p>aminobenzoate potassium decreases effects of sulfamethoxazole by pharmacodynamic antagonism. Avoid or Use Alternate Drug.</p></li><li>amiodarone<p>amiodarone and trimethoprim both increase  QTc interval. Avoid or Use Alternate Drug.<span><br><br></span>amiodarone and sulfamethoxazole both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>antithrombin alfa<p>sulfamethoxazole increases effects of antithrombin alfa by decreasing metabolism. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole increases effects of antithrombin alfa by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>astemizole<p>astemizole and trimethoprim both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>antithrombin iii<p>sulfamethoxazole increases effects of antithrombin iii by decreasing metabolism. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole increases effects of antithrombin iii by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>argatroban<p>sulfamethoxazole increases effects of argatroban by decreasing metabolism. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole increases effects of argatroban by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>astemizole<p>astemizole and sulfamethoxazole both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>bcg vaccine live<p>trimethoprim decreases effects of bcg vaccine live by pharmacodynamic antagonism. Contraindicated. Wait until Abx Tx complete to administer live bacterial vaccine.<span><br><br></span>sulfamethoxazole decreases effects of bcg vaccine live by pharmacodynamic antagonism. Contraindicated. Wait until Abx Tx complete to administer live bacterial vaccine.</p></li><li>bemiparin<p>sulfamethoxazole increases effects of bemiparin by decreasing metabolism. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole increases effects of bemiparin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>cholera vaccine<p>trimethoprim, cholera vaccine. pharmacodynamic antagonism. Avoid or Use Alternate Drug. Avoid coadministration of cholera vaccine with systemic antibiotics since these agents may be active against the vaccine strain. Do not administer cholera vaccine to patients who have received oral or parenteral antibiotics within 14 days prior to vaccination.</p></li><li>bivalirudin<p>sulfamethoxazole increases effects of bivalirudin by decreasing metabolism. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole increases effects of bivalirudin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>cisapride<p>cisapride and sulfamethoxazole both increase  QTc interval. Avoid or Use Alternate Drug.<span><br><br></span>cisapride and trimethoprim both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>cyclosporine<p>sulfamethoxazole decreases effects of cyclosporine by unknown mechanism. Avoid or Use Alternate Drug. Increased nephrotoxicity with this combination.</p></li><li>disopyramide<p>disopyramide and trimethoprim both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>dalteparin<p>sulfamethoxazole increases effects of dalteparin by decreasing metabolism. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole increases effects of dalteparin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>disopyramide<p>sulfamethoxazole and disopyramide both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>enoxaparin<p>sulfamethoxazole increases effects of enoxaparin by decreasing metabolism. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole increases effects of enoxaparin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>fondaparinux<p>sulfamethoxazole increases effects of fondaparinux by decreasing metabolism. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole increases effects of fondaparinux by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>heparin<p>sulfamethoxazole increases effects of heparin by decreasing metabolism. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole increases effects of heparin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>ibutilide<p>sulfamethoxazole and ibutilide both increase  QTc interval. Avoid or Use Alternate Drug.<span><br><br></span>ibutilide and trimethoprim both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>idelalisib<p>idelalisib will increase the level or effect of trimethoprim by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Idelalisib is a strong CYP3A inhibitor; avoid coadministration with sensitive CYP3A substrates</p></li><li>indapamide<p>sulfamethoxazole and indapamide both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>indapamide<p>indapamide and trimethoprim both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>ivacaftor<p>ivacaftor increases levels of trimethoprim by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Ivacaftor and its M1 metabolite has the potential to inhibit CYP3A4, may significantly increase systemic exposure to 3A4 substrates.</p></li><li>lepirudin<p>sulfamethoxazole increases effects of lepirudin by decreasing metabolism. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole increases effects of lepirudin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>leucovorin<p>leucovorin decreases effects of trimethoprim by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Monitor for trimethoprim treatment failure or decreased efficacy when coadministered with leucovorin, especially when used with sulfamethoxazole for  Pneumocystis jiroveci pneumonia in patients who are HIV positive .</p></li><li>levoleucovorin<p>levoleucovorin decreases effects of trimethoprim by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Monitor for trimethoprim treatment failure or decreased efficacy when coadministered with levoleucovorin, especially when used with sulfamethoxazole for  Pneumocystis jiroveci pneumonia in patients who are HIV positive .</p></li><li>mefloquine<p>mefloquine increases toxicity of sulfamethoxazole by QTc interval. Avoid or Use Alternate Drug. Mefloquine may enhance the QTc prolonging effect of high risk QTc prolonging agents.<span><br><br></span>mefloquine increases toxicity of trimethoprim by QTc interval. Avoid or Use Alternate Drug. Mefloquine may enhance the QTc prolonging effect of high risk QTc prolonging agents.</p></li><li>methenamine<p>methenamine, sulfamethoxazole. Other (see comment). Contraindicated. 
Comment: This combination may form an insoluble precipitate in the urine, decreasing the effects of both agents.</p></li><li>methotrexate<p>trimethoprim, methotrexate.
Either increases toxicity of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Due to an additive antifolate effect, trimethoprim has been shown to rarely increase bone marrow suppression in patients receiving methotrexate.</p></li><li>methotrexate<p>sulfamethoxazole increases toxicity of methotrexate by plasma protein binding competition. Avoid or Use Alternate Drug. Methotrexate concentrations may be elevated, increasing the risk of toxicity (eg, bone marrow suppression).</p></li><li>pentamidine<p>pentamidine and trimethoprim both increase  QTc interval. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole and pentamidine both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>phenindione<p>sulfamethoxazole increases effects of phenindione by decreasing metabolism. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole increases effects of phenindione by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>pimozide<p>pimozide and trimethoprim both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>pimozide<p>sulfamethoxazole and pimozide both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>procainamide<p>procainamide and trimethoprim both increase  QTc interval. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole and procainamide both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>protamine<p>sulfamethoxazole increases effects of protamine by decreasing metabolism. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole increases effects of protamine by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>quinidine<p>quinidine and trimethoprim both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>quinidine<p>quinidine and sulfamethoxazole both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>sotalol<p>sulfamethoxazole and sotalol both increase  QTc interval. Avoid or Use Alternate Drug.<span><br><br></span>sotalol and trimethoprim both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>terfenadine<p>terfenadine and trimethoprim both increase  QTc interval. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole and terfenadine both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>tinzaparin<p>sulfamethoxazole increases effects of tinzaparin by decreasing metabolism. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole increases effects of tinzaparin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>typhoid vaccine live<p>trimethoprim decreases effects of typhoid vaccine live by pharmacodynamic antagonism. Contraindicated. Wait until Abx Tx complete to administer live bacterial vaccine.</p></li>